Business Description
Sakar Healthcare Ltd
ISIN : INE732S01012
Compare
Compare
Traded in other countries / regions
SAKAR.India IPO Date
2016-10-14Description
Sakar Healthcare Ltd is engaged in manufacturing Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections. The company offers its products to Sri Lanka, the Philippines, Vietnam, Cambodia, Sudan, Myanmar, Mauritius, Costa Rica, Panama, El Salvador, and Paraguay.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | 1.75 | |||||
| Interest Coverage | 2.69 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.63 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.9 | |||||
| 3-Year EBITDA Growth Rate | 12 | |||||
| 3-Year EPS without NRI Growth Rate | 2.4 | |||||
| 3-Year Book Growth Rate | 23 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.07 | |||||
| 9-Day RSI | 37.04 | |||||
| 14-Day RSI | 39.42 | |||||
| 6-1 Month Momentum % | 21.67 | |||||
| 12-1 Month Momentum % | 84.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.23 | |||||
| Quick Ratio | 0.75 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 74.2 | |||||
| Days Sales Outstanding | 40.94 | |||||
| Days Payable | 84.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.6 | |||||
| Shareholder Yield % | 0.53 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.02 | |||||
| Operating Margin % | 12.85 | |||||
| Net Margin % | 8.26 | |||||
| FCF Margin % | -32.36 | |||||
| ROE % | 6.62 | |||||
| ROA % | 3.77 | |||||
| ROIC % | 5.26 | |||||
| ROC (Joel Greenblatt) % | 8.02 | |||||
| ROCE % | 7.89 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 60.49 | |||||
| PE Ratio without NRI | 60.05 | |||||
| PEG Ratio | 1.77 | |||||
| PS Ratio | 5.01 | |||||
| PB Ratio | 3.44 | |||||
| Price-to-Tangible-Book | 3.44 | |||||
| Price-to-Operating-Cash-Flow | 21.02 | |||||
| EV-to-EBIT | 29.04 | |||||
| EV-to-EBITDA | 16.56 | |||||
| EV-to-Revenue | 4.27 | |||||
| EV-to-FCF | -13.6 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.12 | |||||
| Price-to-Graham-Number | 2.78 | |||||
| Earnings Yield (Greenblatt) % | 3.45 | |||||
| FCF Yield % | -8.46 | |||||
| Forward Rate of Return (Yacktman) % | -76.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sakar Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,509.439 | ||
| EPS (TTM) (₹) | 6.232 | ||
| Beta | 1.24 | ||
| Volatility % | 46.06 | ||
| 14-Day RSI | 39.42 | ||
| 14-Day ATR (₹) | 16.522686 | ||
| 20-Day SMA (₹) | 396.4325 | ||
| 12-1 Month Momentum % | 84.97 | ||
| 52-Week Range (₹) | 191.3 - 479 | ||
| Shares Outstanding (Mil) | 17.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sakar Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sakar Healthcare Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sakar Healthcare Ltd Frequently Asked Questions
What is Sakar Healthcare Ltd(NSE:SAKAR)'s stock price today?
The current price of NSE:SAKAR is ₹376.95. The 52 week high of NSE:SAKAR is ₹479.00 and 52 week low is ₹191.30.
When is next earnings date of Sakar Healthcare Ltd(NSE:SAKAR)?
The next earnings date of Sakar Healthcare Ltd(NSE:SAKAR) is .
Does Sakar Healthcare Ltd(NSE:SAKAR) pay dividends? If so, how much?
Sakar Healthcare Ltd(NSE:SAKAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers